NASDAQ:ZEAL
Delisted
Zealand Pharma Stock News
$17.59
+0 (+0%)
At Close: Jan 27, 2023
Zealand Pharma A/S – Transaction Under Share Repurchase Program
04:05pm, Tuesday, 13'th Jul 2021
C ompany a nnouncement – No. 4 6 / 202 1
ZEALAND PHARMA A/S - TRANSACTIONS UNDER SHARE REPURCHASE PROGRAM
11:55am, Tuesday, 06'th Jul 2021
Company announcement – No. 45 / 202 1
Zealand Pharma A/S - Share Buy-Back Program Under Safe Harbour to Aquire Danish Common Stock for Employee Incentive Programs
04:05pm, Monday, 28'th Jun 2021
Company announcement – No. 42/ 2021
Zealand Pharma Announces U.S. Commercial Availability of ZEGALOGUE® (dasiglucagon) injection
07:00am, Thursday, 24'th Jun 2021
C ompany a nnouncement – No. 41 / 202 1
Zealand Pharma to Participate in LifeSci Nordic Biotech Summit
04:05pm, Tuesday, 22'nd Jun 2021
C ompany a nnouncement – No. 40 / 202 1
Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at the 81st Annual American Diabetes Association Scientific Sessions
08:06am, Wednesday, 16'th Jun 2021
C ompany a nnouncement – No. 39/ 202 1
Company announcement – No. 38 / 20 2 1
Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
04:05pm, Thursday, 03'rd Jun 2021
C ompany a nnouncement – No. 36 / 202 1
Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH
08:05am, Wednesday, 02'nd Jun 2021
C ompany a nnouncement – No. 35 / 202 1
Company announcement – No. 34 / 20 2 1
Zealand Pharma launches long-term incentive program for Zealand's US based Corporate Management for 2021
10:00am, Thursday, 27'th May 2021
Company announcement – No. 33 / 20 2 1
Zealand Pharma to participate in Jefferies Virtual Healthcare Conference
04:05pm, Wednesday, 26'th May 2021
C ompany a nnouncement – No. 32 / 202 1
Zealand Pharma AS (ZEAL) Moves 8.3% Higher: Will This Strength Last?
09:46am, Wednesday, 19'th May 2021
Zealand Pharma AS (ZEAL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near ter
Company announcement – No. 30 / 20 2 1
Zealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q1 2021 Results - Earnings Call Transcript
02:35pm, Wednesday, 12'th May 2021
Zealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q1 2021 Results - Earnings Call Transcript
